Generation and tumor recognition properties of two human monoclonal antibodies specific to cell surface anionic phospholipids

详细信息    查看全文

• 作者：Emil Bujak ; Francesca Pretto ; Dario Neri
• 关键词：Phosphatidylserine ; Phage display ; Antibody ; Small immune protein (SIP) ; Pharmacodelivery ; Tumor targeting
• 刊名：Investigational New Drugs
• 出版年：2015
• 出版时间：August 2015
• 年：2015
• 卷：33
• 期：4
• 页码：791-800
• 全文大小：4,098 KB
• 参考文献：1.Fadok VA, de Cathelineau A, Daleke DL, Henson PM, Bratton DL (2001) Loss of phospholipid asymmetry and surface exposure of phosphatidylserine is required for phagocytosis of apoptotic cells by macrophages and fibroblasts. J Biol Chem 276(2):1071鈥?077. doi:10.鈥?074/鈥媕bc.鈥婱003649200 PubMed View Article
  2.Fischer K, Voelkl S, Berger J, Andreesen R, Pomorski T, Mackensen A (2006) Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells. Blood 108(13):4094鈥?101PubMed View Article
  3.Ran S, Thorpe PE (2002) Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int J Radiat Oncol 54(5):1479鈥?484. doi:10.鈥?016/鈥媠0360-3016(02)03928-7 View Article
  4.Riedl S, Rinner B, Asslaber M, Schaider H, Walzer S, Novak A, Lohner K, Zweytick D (2011) In search of a novel target 鈥?phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy. BBA Biomembr 1808(11):2638鈥?645. doi:10.鈥?016/鈥媕.鈥媌bamem.鈥?011.鈥?7.鈥?26 View Article
  5.Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ (1991) Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumor cells and recognition by activated human blood monocytes. Cancer Res 51(11):3062鈥?066PubMed
  6.Yagle KJ, Eary JF, Tait JF, Grierson JR, Link JM, Lewellen B, Gibson DF, Krohn KA (2005) Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis. J Nucl Med 46(4):658鈥?66PubMed
  7.Zhao D, Stafford JH, Zhou H, Thorpe PE (2011) Near-infrared optical imaging of exposed phosphatidylserine in a mouse glioma model. Transl Oncol 4(6):355鈥?64PubMed Central PubMed View Article
  8.Hofstra L, Liem IH, Dumont EA, Boersma HH, van Heerde WL, Doevendans PA, DeMuinck E, Wellens HJJ, Kemerink GJ, Reutelingsperger CPM, Heidendal GA (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356(9225):209鈥?12. doi:10.鈥?016/鈥婼0140-6736(00)02482-X PubMed View Article
  9.Kietselaer BLJH, Reutelingsperger CPM, Boersma HH, Heidendal GAK, Liem IH, Crijns HJGM, Narula J, Hofstra L (2007) Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure. J Nucl Med 48(4):562鈥?67. doi:10.鈥?967/鈥媕numed.鈥?06.鈥?39453 PubMed View Article
  10.Kolodgie FD, Petrov A, Virmani R, Narula N, Verjans JW, Weber DK, Hartung D, Steinmetz N, Vanderheyden JL, Vannan MA, Gold HK, Reutelingsperger CPM, Hofstra L, Narula J (2003) Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108(25):3134鈥?139. doi:10.鈥?161/鈥?1.鈥媍ir.鈥?000105761.鈥?0573.鈥?0 PubMed View Article
  11.Lampl Y, Lorberboym M, Blankenberg FG, Sadeh M, Gilad R (2006) Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia. Neurology 66(8):1253鈥?254. doi:10.鈥?212/鈥?1.鈥媤nl.鈥?000208436.鈥?5615.鈥?c PubMed View Article
  12.Narula J, Acio ER, Narula N, Samuels LE, Fyfe B, Wood D, Fitzpatrick JM, Raghunath PN, Tomaszewski JE, Kelly C, Steinmetz N, Green A, Tait JF, Leppo J, Blankenberg FG, Jain D, Strauss HW (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7(12):1347鈥?352PubMed View Article
  13.Post AM, Katsikis PD, Tait JF, Geaghan SM, Strauss HW, Blankenberg FG (2002) Imaging cell death with radiolabeled annexin V in an experimental model of rheumatoid arthritis. J Nucl Med 43(10):1359鈥?365PubMed
  14.Bondanza A, Zimmermann VS, Rovere-Querini P, Turnay J, Dumitriu IE, Stach CM, Voll RE, Gaipl US, Bertling W, P枚schl E, Kalden JR, Manfredi AA, Herrmann M (2004) Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J Exp Med 200(9):1157鈥?165. doi:10.鈥?084/鈥媕em.鈥?0040327 PubMed Central PubMed View Article
  15.He J, Yin Y, Luster TA, Watkins L, Thorpe PE (2009) Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clin Cancer Res 15(22):6871鈥?880. doi:10.鈥?158/鈥?078-0432.鈥媍cr-09-1499 PubMed View Article
  16.Huang X, Bennett M, Thorpe PE (2005) A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice. Cancer Res 65(10):4408鈥?416. doi:10.鈥?158/鈥?008-5472.鈥媍an-05-0031 PubMed View Article
  17.Ran S, He J, Huang X, Soares M, Scothorn D, Thorpe PE (2005) Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clin Cancer Res 11(4):1551鈥?562. doi:10.鈥?158/鈥?078-0432.鈥媍cr-04-1645 PubMed View Article
  18.Beck AW, Luster TA, Miller AF, Holloway SE, Conner CR, Barnett CC, Thorpe PE, Fleming JB, Brekken RA (2006) Combination of a monoclonal anti-phosphatidylserine antibody with gemcitabine strongly inhibits the growth and metastasis of orthotopic pancreatic tumors in mice. Int J Cancer 118(10):2639鈥?643. doi:10.鈥?002/鈥媔jc.鈥?1684 PubMed View Article
  19.Luster TA, He J, Huang X, Maiti SN, Schroit AJ, de Groot PG, Thorpe PE (2006) Plasma protein 尾-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells. J Biol Chem 281(40):29863鈥?9871. doi:10.鈥?074/鈥媕bc.鈥婱605252200 PubMed View Article
  20.Tomasi M, Hiromasa Y, Pope MR, Gudlur S, Tomich JM, Fleming SD (2012) Human 尾2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation. Mol Immunol 52(3鈥?):207鈥?16. doi:10.鈥?016/鈥媕.鈥媘olimm.鈥?012.鈥?5.鈥?18 PubMed Central PubMed View Article
  21.Stafford JH, Hao G, Best AM, Sun X, Thorpe PE (2013) Highly specific PET imaging of prostate tumors in mice with an iodine-124-labeled antibody fragment that targets phosphatidylserine. PLoS ONE 8(12), e84864. doi:10.鈥?371/鈥媕ournal.鈥媝one.鈥?084864 PubMed Central PubMed View Article
  22.Wahl RL, Parker CW, Philpott GW (1983) Improved radioimaging and tumor localization with monoclonal F(ab鈥?2. J Nucl Med 24(4):316鈥?25PubMed
  23.Weber M, Bujak E, Putelli A, Villa A, Matasci M, Gualandi L, Hemmerle T, Wulhfard S, Neri D (2014) A highly functional synthetic phage display library containing over 40 billion human antibody clones. PLoS ONE 9(6), e100000. doi:10.鈥?371/鈥媕ournal.鈥媝one.鈥?100000 PubMed Central PubMed View Article
  24.Borsi L, Balza E, Bestagno M, Castellani P, Carnemolla B, Biro A, Leprini A, Sepulveda J, Burrone O, Neri D, Zardi L (2002) Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin. Int J Cancer 102:75鈥?5PubMed View Article
  25.Zuberb眉hler K, Palumbo A, Bacci C, Giovannoni L, Sommavilla R, Kaspar M, Trachsel E, Neri D (2009) A general method for the selection of high-level scFv and IgG antibody expression by stably transfected mammalian cells. Protein Eng Des Sel 22(3):169鈥?74. doi:10.鈥?093/鈥媝rotein/鈥媑zn068 PubMed View Article
  26.Villa A, Trachsel E, Kaspar M, Schliemann C, Sommavilla R, Rybak J, Rosli C, Borsi L, Neri D (2008) A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculature in vivo. Int J Cancer 122:2405鈥?413PubMed View Article
  27.Frey K, Zivanovic A, Schwager K, Neri D (2011) Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation. Integr Biol 3(4):468鈥?78. doi:10.鈥?039/鈥媍0ib00099j View Article
  28.Rybak J-N, Roesli C, Kaspar M, Villa A, Neri D (2007) The extra-domain a of fibronectin is a vascular marker of solid tumors and metastases. Cancer Res 67(22):10948鈥?0957. doi:10.鈥?158/鈥?008-5472.鈥媍an-07-1436 PubMed View Article
  29.Purpura M, Jager R, Joy J, Lowery R, Moore J, Wilson J (2013) Effect of oral administration of soy-derived phosphatidic acid on concentrations of phosphatidic acid and lyso-phosphatidic acid molecular species in human plasma. Int J Sport Nutr 10(Suppl 1):P22View Article
  30.Mills GB, Moolenaar WH (2003) The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3(8):582鈥?91PubMed View Article
  31.Noh J-Y, Lim K-M, Bae O-N, Chung S-M, Lee S-W, Joo K-M, Lee S-D, Chung J-H (2010) Procoagulant and prothrombotic activation of human erythrocytes by phosphatidic acid, vol 299. vol 2. doi:10.鈥?152/鈥媋jpheart.鈥?1144.鈥?009
  32.Leventis PA, Grinstein S (2010) The distribution and function of phosphatidylserine in cellular membranes. Annu Rev Biophys 39(1):407鈥?27. doi:10.鈥?146/鈥媋nnurev.鈥媌iophys.鈥?93008.鈥?31234 PubMed View Article
  33.Fridriksson EK, Shipkova PA, Sheets ED, Holowka D, Baird B, McLafferty FW (1999) Quantitative analysis of phospholipids in functionally important membrane domains from RBL-2H3 mast cells using tandem high-resolution mass spectrometry鈥? Biochemistry 38(25):8056鈥?063. doi:10.鈥?021/鈥媌i9828324 PubMed View Article
  34.Bevers E, Comfurius P, Zwaal R (1996) Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications. Lupus 5(5):480鈥?87. doi:10.鈥?177/鈥?961203396005005鈥?1 PubMed
  35.Peregrine (2014) Data presented at ASCO shows promising 11.7 month median overall survival in second- line NSCLC patients treated with Peregrine Pharmaceuticals鈥?novel immunotherapy bavituximab. Accessed 27 June 2014
  36.Lorberboym M, Blankenberg FG, Sadeh M, Lampl Y (2006) In vivo imaging of apoptosis in patients with acute stroke: correlation with blood鈥揵rain barrier permeability. Brain Res 1103(1):13鈥?9. doi:10.鈥?016/鈥媕.鈥媌rainres.鈥?006.鈥?5.鈥?73 PubMed View Article
  37.Belhocine T, Steinmetz N, Hustinx R, Bartsch P, Jerusalem G, Seidel L, Rigo P, Green A (2002) Increased uptake of the apoptosis-imaging agent 99mTc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clin Cancer Res 8(9):2766鈥?774PubMed
  38.Schlaepfer DD, Haigler HT (1987) Characterization of Ca2鈥?鈥夆垝dependent phospholipid binding and phosphorylation of lipocortin I. J Biol Chem 262(14):6931鈥?937PubMed
  39.Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM (1990) Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 265(9):4923鈥?928PubMed
  40.Tait JF, Gibson D (1992) Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. Arch Biochem Biophys 298(1):187鈥?91. doi:10.鈥?016/鈥?003-9861(92)90111-9 PubMed View Article
  41.Andree HA, Stuart MC, Hermens WT, Reutelingsperger CP, Hemker HC, Frederik PM, Willems GM (1992) Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 267(25):17907鈥?7912PubMed
  42.Mosser G, Ravanat C, Freyssinet J-M, Brisson A (1991) Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J Mol Biol 217(2):241鈥?45. doi:10.鈥?016/鈥?022-2836(91)90538-H PubMed View Article
  43.Tait JF, Gibson D, Fujikawa K (1989) Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 264(14):7944鈥?949PubMed
  44.Pfaffen S, Frey K, Stutz I, Roesli C, Neri D (2010) Tumour-targeting properties of antibodies specific to MMP-1A, MMP-2 and MMP-3. Eur J Nucl Med Mol Imaging 37(8):1559鈥?565. doi:10.鈥?007/鈥媠00259-010-1446-9 PubMed View Article
  45.Silacci M, Brack S, Schirru G, Marlind J, Ettorre A, Merlo A, Viti F, Neri D (2005) Design, construction, and characterization of a large synthetic human antibody phage display library. Proteomics 5:2340鈥?350PubMed View Article
  46.List T, Neri D (2012) Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor site. mAbs 4(6):775鈥?83PubMed Central PubMed View Article
  47.Silacci M, Brack S, Spath N, Buck A, Hillinger S, Arni S, Weder W, Zardi L, Neri D (2006) Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo. Protein Eng Des Sel 19:471鈥?78PubMed View Article
  48.Tarli L, Balza E, Viti F, Borsi L, Castellani P, Berndorff D, Dinkelborg L, Neri D, Zardi L (1999) A high-affinity human antibody that targets tumoral blood vessels. Blood 94(1):192鈥?98PubMed
  49.Fraker PJ (2012) Reprint of 鈥淧rotein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-Tetrachloro-3a,6a-Diphenylglycoluril鈥? Biochem Biophys Res Commun 425(3):510鈥?18. doi:10.鈥?016/鈥媕.鈥媌brc.鈥?012.鈥?8.鈥?17 PubMed View Article
  50.Salacinski PRP, McLean C, Sykes JEC, Clement-Jones VV, Lowry PJ (1981) Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 1,3,4,6-tetrachloro-3伪,6伪-diphenyl glycoluril (Iodogen). Anal Biochem 117(1):136鈥?46. doi:10.鈥?016/鈥?003-2697(81)90703-X PubMed View Article
  
• 作者单位：Emil Bujak (1)
  Francesca Pretto (2)
  Dario Neri (1)
  
  1. Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Z眉rich, Vladimir-Prelog-Weg 2, CH-8093, Zurich, Switzerland
  2. Philochem AG, Libernstrasse 3, CH-8112, Otelfingen, Switzerland
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Oncology
  Pharmacology and Toxicology
  
• 出版者：Springer Netherlands
• ISSN：1573-0646

文摘